Clinical Trial

Time to BBVNA Relief

Recruiting
View on ClinicalTrials.gov →
Summary
Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-19.
Trial Details
NCT Number NCT07433634
Lead Sponsor Yale University
Conditions Low Back Pain, Vertebrogenic Pain Syndrome, Basivertebral Nerve Ablation
Enrollment 200 participants
Start Date 2024-04-19
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-03